These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 34384494)
1. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs. Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494 [TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs. Austin EJ; Gojic AJ; Bhatraju EP; Pierce KA; Pickering EI; Tung EL; Scott JD; Hansen RN; Glick SN; Stekler JD; Connolly NC; Villafuerte S; McPadden M; Deutsch S; Ninburg M; Kubiniec R; Williams EC; Tsui JI Int J Drug Policy; 2023 Jan; 111():103924. PubMed ID: 36521197 [TBL] [Abstract][Full Text] [Related]
3. "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments. Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R Int J Equity Health; 2021 Mar; 20(1):81. PubMed ID: 33740984 [TBL] [Abstract][Full Text] [Related]
4. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs. Goodyear T; Ti L; Carrieri P; Small W; Knight R Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525 [TBL] [Abstract][Full Text] [Related]
5. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968 [TBL] [Abstract][Full Text] [Related]
6. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington. Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152 [TBL] [Abstract][Full Text] [Related]
7. Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale-up of direct-acting anti-viral therapy in community drug services: real-world data. Palmateer NE; McAuley A; Dillon JF; McDonald S; Yeung A; Smith S; Barclay S; Hayes P; Shepherd SJ; Gunson RN; Goldberg DJ; Hickman M; Hutchinson SJ Addiction; 2021 Oct; 116(10):2893-2907. PubMed ID: 33651446 [TBL] [Abstract][Full Text] [Related]
8. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada. Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340 [TBL] [Abstract][Full Text] [Related]
9. Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma. Austin EJ; Tsui JI; Barry MP; Tung E; Glick SN; Ninburg M; Williams EC J Subst Abuse Treat; 2022 Jun; 137():108684. PubMed ID: 34911656 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493 [TBL] [Abstract][Full Text] [Related]
11. 'Hep C's like the common cold': understanding barriers along the HCV care continuum among young people who inject drugs. Skeer MR; Ladin K; Wilkins LE; Landy DM; Stopka TJ Drug Alcohol Depend; 2018 Sep; 190():246-254. PubMed ID: 30071457 [TBL] [Abstract][Full Text] [Related]
12. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB; Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989 [TBL] [Abstract][Full Text] [Related]
13. Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs. Karasz A; Singh R; McKee MD; Merchant K; Kim AY; Page K; Pericot-Valverde I; Stein ES; Taylor LE; Wagner K; Litwin AH J Subst Abuse Treat; 2022 Sep; 140():108768. PubMed ID: 35729038 [TBL] [Abstract][Full Text] [Related]
14. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy. Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585 [TBL] [Abstract][Full Text] [Related]
15. Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH). Mora M; Goodyear T; Marcellin F; Shoveller J; Di Beo V; Calzolaio C; Sogni P; Wittkop L; Zucman D; Poizot-Martin I; Lacombe K; Salmon-Céron D; Knight R; Carrieri P J Viral Hepat; 2020 Dec; 27(12):1462-1472. PubMed ID: 32810905 [TBL] [Abstract][Full Text] [Related]
16. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol. Klaman SL; Godino JG; Northrup A; Lewis SV; Tam A; Carrillo C; Lewis R; Matthews E; Mendez B; Reyes L; Rojas S; Ramers C BMC Infect Dis; 2024 Jan; 24(1):105. PubMed ID: 38238686 [TBL] [Abstract][Full Text] [Related]
17. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA. Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005 [TBL] [Abstract][Full Text] [Related]
18. Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis. Marquez LK; Cepeda JA; Bórquez A; Strathdee SA; Gonzalez-Zúñiga PE; Fleiz C; Rafful C; Garfein RS; Kiene SM; Brodine S; Martin NK Int J Drug Policy; 2021 Feb; 88():102710. PubMed ID: 32165050 [TBL] [Abstract][Full Text] [Related]
19. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C). Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Molès JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D; BMJ Open; 2020 Nov; 10(11):e039234. PubMed ID: 33208326 [TBL] [Abstract][Full Text] [Related]
20. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs. Yeung A; Palmateer NE; Dillon JF; McDonald SA; Smith S; Barclay S; Hayes PC; Gunson RN; Templeton K; Goldberg DJ; Hickman M; Hutchinson SJ J Hepatol; 2022 Mar; 76(3):549-557. PubMed ID: 34634387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]